|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：D689962 |
| 產(chǎn)品名稱：L-threo-Droxidopa-13C2,15N |
| 產(chǎn)品CAS：1276295-04-5 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
D689962 |
| 名稱: |
L-threo-Droxidopa-13C2,15N |
| 別名: |
(βR)-β,3-Dihydroxy-L-tyrosine-13C2,15N; threo-β,3-Dihydroxy-L-tyrosine-13C2,15N; L-threo-3-(3,4-Dihydroxyphenyl)serine-13C2,15N; (-)-threo-3,4-Dihydroxyphenyl- serine-13C2,15N; (2S,3R)-3-(3,4-Dihydroxyphenyl)-2-amino-3-hydroxypropanoic Acid-13C2,15N; L-DOPS-13C2,15N; L-Threodops-13C2,15N; L-threo-3,4-Dihydroxyphenyl- serine-13C2,15N; L-threo-β-(3,4-Dihydroxyphenyl)serine-13C2,15N; SM 5688-13C2,15N; threo-Dopaserine-13C2,15N; |
| CAS號(hào): |
1276295-04-5 |
| 參考CAS: |
23651-95-8-unlabelled |
| 分子式: |
C?¹³C?H??¹?NO? |
| 分子量: |
216.17 |
| 種類: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
The L-threo-form Droxidopa. A synthetic amino acid precursor of Norepinephrine (N674500). Antiparkinsonian. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
